GlassScriptPhysician profile
Anna Morgan Clow
NPI 1861962953
$1,766.79
in general payments reported to CMS, 2019-2025
11 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,129 · Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,128.75 |
| Food and Beverage | $411.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mf Med | $863.53 | 2025 | |
| Arthrex, INC. | $676.40 | 2025 | |
| Lilly USA, LLC | $42.15 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $37.51 | 2021 | |
| Pfizer INC. | $36.77 | 2021 | |
| Abbvie INC. | $32.43 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.91 | 2021 | |
| Amarin Pharma, INC. | $16.02 | 2021 | |
| Mylan Specialty L.P. | $15.64 | 2021 | |
| Novo Nordisk INC | $15.59 | 2021 | |
| Glaxosmithkline, LLC. | $11.84 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Clow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.